Possibly. I dunno. Who knows?
For me the rise from around $270 in July to retesting ATHs in Nov last year was completely unwarranted, then oversold massively on inflation/ ongoing pandemic concerns this year.
Its been acting a bit all over the shop over the past year in my view.
The action since March seems to make more sense to me. Pandemic worries dying down, collection data coming out which is giving more clarity and certainty, and potential involvment in new mrna technology are real and noted reasons for sustained increases.
Possibly. I dunno. Who knows?For me the rise from around $270 in...
-
- There are more pages in this discussion • 448 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$305.74 |
Change
-1.420(0.46%) |
Mkt cap ! $147.7B | |||
| Open | High | Low | Value | Volume |
| $306.75 | $307.16 | $302.85 | $128.0M | 420.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $305.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $305.80 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| CSL (ASX) Chart |